How to identify epileptogenic zone in MRI negative epilepsy with arterial spin labelling data


March 16, 2022
Brno Node User Forum MRI Neuroscience User stories

Euro-BioImaging is organizing an online User Forum on April 5, 2022, from 14:00-17:00 CEST. This event will highlight the importance of cutting-edge imaging technologies in support of brain research and showcase the specific expertise available at our Nodes across Europe through case studies presented in tandem with the research community.

In this brief abstract, learn how Martin Gajdoš, CEITEC Masaryk University, worked with the experts at ALM and Medical Imaging Node Brno in Czechia, to demonstrate that arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI) can help with localization of the epileptogenic zone (EZ) and thus help epileptologists to increase the reliability of their decisions.

Hear this talk and others like it on April 5 at the Euro-BioImaging User Forum: At the Forefront of Neuroscience.

REGISTER

FULL PROGRAM

How to identify epileptogenic zone in MRI negative epilepsy with arterial spin labelling data

Martin Gajdoš, CEITEC Masaryk University
Michal Mikl, ALM and Medical Imaging Node Brno

Drug-resistant epilepsy is a diagnostic and therapeutic challenge, mainly in patients with negative MRI findings. State-of-the-art imaging methods complement standard epilepsy protocols with new information and help epileptologists to increase the reliability of their decisions.

In this work, we show the ability of arterial spin labeling (ASL) perfusion MRI to help with localization of the epileptogenic zone (EZ). We present an image processing method to detect the EZ as an area with hypoperfusion relative to the contralateral unaffected side, using subject-specific thresholding of the asymmetry index in ASL images. We demonstrate three thresholding criteria (termed minimal product criterion, minimal distance criterion, and elbow criterion) on 29 patients with MRI-negative epilepsy (age 32.98 ± 10.4 years). The minimal product criterion showed optimal results in terms of positive predictive value (mean 0.12 in postoperative group and 0.22 in preoperative group) and true positive rate (mean 0.71 in postoperative group and 1.82 in preoperative group). Additionally, we found high accuracy in determining the EZ side (mean 0.86 in postoperative group and 0.73 in preoperative group out of 1.00). ASL can be easily incorporated into the standard presurgical MR protocol, and it provides an additional benefit in EZ localization.


More news from Euro-BioImaging

Scientific Ambassadors activities

December 17, 2024

Celebrating Euro-BioImaging’s Scientific Ambassadors

In March 2024, Euro-BioImaging onboarded the first pilot cohort of Scientific Ambassadors, a group of 12 highly motivated individuals whose dedication and passion for…

December 17, 2024

Highlights from foundingGIDE Community Event 2024

foundingGIDE is a project coordinated by Euro-BioImaging and funded under the European Commission’s Horizon Europe framework program. foundingGIDE is dedicated to enabling the interoperability…

France-BioImaging Annual Meeting 2024 in Strasbourg. Photo courtesy of France-BioImaging.

December 16, 2024

Congratulations, France-BioImaging!

2024 will stand out in France-BioImaging history as a very positive year. Not only was France-BioImaging awarded significant national funding to support their infrastructure…